Certifications are non-negotiable in medical device trade. Unlike other product categories where certifications may be 'nice to have,' medical devices require specific regulatory approvals for market access. The certification landscape changed significantly in 2026, making it essential for suppliers and buyers to understand current requirements.
FDA Quality Management System Regulation (QMSR) - Effective February 2, 2026:
The U.S. FDA finalized a major regulatory change that impacts all medical device suppliers targeting the American market. The QMSR amends 21 CFR Part 820 to incorporate ISO 13485:2016 by reference. This means ISO 13485 compliance is now effectively mandatory for U.S. market access [2].
Key points buyers should understand:
- The FDA will not require suppliers to hold ISO 13485 certificates from third-party registrars
- However, manufacturers must demonstrate compliance with ISO 13485 quality management system requirements
- FDA-only requirements still apply in addition to ISO 13485 provisions
- This alignment reduces duplication for manufacturers serving multiple markets
CE Marking (European Union):
CE marking remains mandatory for medical devices sold in the European Economic Area. Under the EU Medical Device Regulation (MDR) 2017/745, devices are classified into Class I, IIa, IIb, and III based on risk level. Most injection and infusion instruments fall into Class I or IIa, requiring notified body involvement for higher-risk categories.
ISO 13485:2016 (International Quality Management):
This is the global standard for medical device quality management systems. While not a product certification per se, ISO 13485 certification of the manufacturer is often a prerequisite for B2B contracts, especially with hospital groups and government procurement agencies.
Additional Certifications by Market:
| Certification |
Primary Market |
Relevance for Injection/Infusion Devices |
| FDA 510(k) |
United States |
Required for most Class II devices |
| CE MDR |
European Union |
Mandatory for EU market access |
| ISO 13485 |
Global |
Quality management system standard |
| WHO Prequalification |
UN Procurement |
Required for WHO tenders |
| Country-Specific Registration |
Individual markets |
e.g., Malaysia MDA, Vietnam MOH |
Southeast Asia Regulatory Updates (2026):
Malaysia's Medical Device Authority issued Circular No. 1/2026 effective January 28, 2026, clarifying that participation in procurement tenders constitutes 'placing on the market' activities. This means suppliers must hold valid establishment licenses and demonstrate GDPMD (Good Distribution Practice for Medical Devices) compliance before bidding on tenders [3].
Vietnam introduced new medical device classification guidelines (Circular 57) in January 2026, with formal implementation expected January 1, 2027. The reforms aim to streamline classification but require careful attention to technical standards determined by Vietnamese law [3].
All countries require regulations/compliances. Buyer will ask how long/where have you already exported to. They might deduct payment on quality/sub standard issue. [7]
Discussion on medical devices export business, regulatory compliance mandatory for B2B transactions
